Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash Equivalents | 301.41 | 228.06 | 490.11 | 115.49 |
Short Term Investments | 90.37 | - | - | - |
Cashand Short Term Investments | 391.78 | 283.82 | 512.16 | 115.60 |
Accounts Receivable- Trade Net | 765.43 | 806.77 | 673.49 | 619.50 |
Total Receivables Net | 765.43 | 918.95 | 715.21 | 726.84 |
Total Inventory | 666.59 | 604.17 | 516.24 | 513.42 |
Other Current Assets Total | 92.19 | 43.26 | 20.81 | 42.24 |
Total Current Assets | 1,916.00 | 1,850.34 | 1,764.58 | 1,399.04 |
Property/ Plant/ Equipment Total- Gross | 101.19 | 975.86 | 789.32 | 656.26 |
Property/ Plant/ Equipment Total- Net | 896.20 | 824.24 | 676.34 | 578.99 |
Intangibles Net | 14.85 | 18.00 | 10.38 | 7.91 |
Long Term Investments | 11.11 | 8.29 | 5.64 | 8.62 |
Note Receivable- Long Term | 3.67 | - | 0.00 | 1.15 |
Other Long Term Assets Total | 8.58 | 1.27 | 14.07 | 1.36 |
Total Assets | 2,850.41 | 2,702.15 | 2,471.01 | 1,997.08 |
Accounts Payable | 368.66 | 409.50 | 324.40 | 222.60 |
Accrued Expenses | 12.03 | 55.09 | 42.06 | 20.43 |
Current Portof LT Debt/ Capital Leases | 2.39 | 2.27 | 1.68 | - |
Other Currentliabilities Total | 55.69 | 37.56 | 15.85 | 978.41 |
Total Current Liabilities | 438.77 | 504.41 | 384.00 | 1,221.44 |
Capital Lease Obligations | 14.76 | 17.09 | 1.20 | - |
Total Long Term Debt | 14.76 | 17.09 | 1.20 | 0.00 |
Total Debt | 17.15 | 19.36 | 2.88 | 0.00 |
Deferred Income Tax | 48.79 | 42.43 | 31.50 | 22.89 |
Other Liabilities Total | 15.77 | - | - | - |
Total Liabilities | 518.09 | 563.94 | 416.70 | 1,244.33 |
Common Stock Total | 24.51 | 24.51 | 24.51 | 1.96 |
Retained Earnings( Accumulated Deficit) | 2,307.82 | 1,108.75 | 1,024.85 | 750.79 |
Total Equity | 2,332.32 | 2,138.21 | 2,054.31 | 752.75 |
Total Liabilities Shareholders' Equity | 2,850.41 | 2,702.15 | 2,471.01 | 1,997.08 |
Total Common Shares Outstanding | 12.25 | 12.25 | 12.25 | 12.25 |
Tangible Book Valueper Share Common Eq | 189.14 | 173.04 | 166.81 | 60.79 |
Cash | - | 55.76 | 22.05 | 0.11 |
Prepaid Expenses | - | 0.14 | 0.16 | 0.94 |
Accumulated Depreciation Total | - | -151.62 | -112.99 | -77.28 |
Notes Payable/ Short Term Debt | - | 0.00 | 0.00 | 0.00 |
Additional Paid- In Capital | - | 1,004.96 | 1,004.96 | - |
Glenmark Life Sciences Dividend Glenmark Life Sciences Bonus Glenmark Life Sciences News Glenmark Life Sciences AGM Glenmark Life Sciences Rights Glenmark Life Sciences Splits Glenmark Life Sciences Board Meetings Glenmark Life Sciences Key Metrics Glenmark Life Sciences Shareholdings Glenmark Life Sciences Profit Loss Glenmark Life Sciences Cashflow Glenmark Life Sciences Q1 Results Glenmark Life Sciences Q2 Results Glenmark Life Sciences Q3 Results Glenmark Life Sciences Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks